Moderate riskFDA DrugClass III

Somerset Therapeutics cisatracurium besylate injection recalled for subpotent drug substance

Somerset Therapeutics is recalling cisatracurium besylate injection (a muscle relaxant used during surgery) because stability testing found the drug strength fell below the required standard. Lot A250043 with expiration date 06/30/2026 is affected. The company has not reported any injuries.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using cisatracurium besylate injection from lot A250043 (NDC 70069-161-01) immediately
  2. Contact your pharmacy or hospital to verify you have not received affected vials
  3. Ask your healthcare provider or pharmacist for guidance on alternative medications if needed
  4. Report any adverse effects to FDA MedWatch at 1-888-SAFEMED or online

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
71,310 10mL vials
Illnesses reported
None reported
Manufactured in
300 Franklin Square Dr, Somerset, NJ, United States
Classification
Class III
Recall number
D-0238-2026

In the FDA's words

Description
Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01. Subpotent product:out of specification assay results observed during long term stability testing. Lot#: A250043, EXP Date 06/30/2026 Distribution: Nationwide in the USA Affected quantity: 71,310 10mL vials
Hazard
Subpotent product:out of specification assay results observed during long term stability testing.

3 products in this recall

Somerset cisatracurium injection recalled for low potency

Somerset Therapeutics is recalling three cisatracurium besylate injection products because testing found the drug may be weaker than its label states. The recall covers 10 mg/5 mL, 200 mg/20 mL and 20 mg/10 mL vials, all made by Somerset Therapeutics in India and distributed nationwide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug